30cents today :), page-5

Some damage control has been going on this morning in the comments at the Admedus Facebook page...


Leigh R. Thomas In years, yes "years" to come, this company has the potential to ease the suffering and save the lives of millions of people. But hey, if want to make a quick buck, perhaps your chances are better playing the pokies.

11 hrs


Admedus Hi Leigh, in addition to quarter on quarter growth in CardioCel sales, both our immunotherapies and regenerative tissue programs continue to prosper and we are looking to grow revenues further as we expand the regenerative tissue product portfolio. Admedus has an exciting future ahead back by quality science, technology and products.

15 mins


Luke Benbow Agreed, hard to believe we were once north of 17 cents....and to think bonuses were recently handed out....apparently us shareholders come a distant 2nd or 3rd or fourth...

2 · 14 hrs


Admedus Hi Luke, we do not believe the current share price reflects the value within Admedus and the successes the Company continues to have across its product range and technology platforms. If you would like to direct message us your contact details we can arrange a phone call to address your comments in person.

18 mins


Sarah Slaven Craig How about an update, soon, then? Before the share price heads back to pre-consolidation levels (6.9cents)?

5 · 15 hrs


Admedus Hi Sarah, we’re currently working closely with our study coordinators to get solid timelines for releasing interim data on our Phase II HSV-2 study. We will communicate
updates on this timing and interim data as soon as it is made available to us.